论文信息 - LBA19 Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer (PHILA): A randomized phase III trial - 字舞流文

LBA19 Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer (PHILA): A randomized phase III trial

Ming Yan | Yu Wang | T. Sun | J. Zhong | W. Li | C. Geng | X. Zeng | T. Luo | Z. Tong | Q. Ouyang | Y. Teng | F. Ma | S. Wang | S. Wu | F. Dong | Q. Liu | Q. Zhang | Q. Mo | X. Zhu | B. Xu